參考文獻(xiàn)/References:
[1] 邱貴興,裴福興,胡偵明,等.中國骨質(zhì)疏松性骨折診療指南(骨質(zhì)疏松性骨折診斷及治療原則)[J].中華骨與關(guān)節(jié)外科雜志,2015,8(5):371-374.
[2] 張穎,何偉,劉又文,等.偏心固定與髓內(nèi)固定治療股骨轉(zhuǎn)子間骨折的病例對照研究[J].中國骨傷,2015,28(2):117-121.
[3] 王福權(quán).關(guān)于老年股骨粗隆間骨折的治療[J].骨與關(guān)節(jié)損傷雜志,1995,10(4):202-204.
[4] JENSEN JS.Classification of trochanteric fractures[J].Acta Orthop Scand,1980,51(5):803-810.
[5] 鄭筱萸.中藥新藥臨床研究指導(dǎo)原則(試行)[M].北京:中國醫(yī)藥科技出版社,2002:356-360.
[6] 蘇繼承.骨傷科康復(fù)技術(shù)[M].北京:人民衛(wèi)生出版社,2008:407-409.
[7] SETIOBUDI T,NG YH,LIM CT,et al.Clinical outcome following treatment of stable and unstable intertrochanteric fractures with dynamic hip screw[J].Ann Acad Med Singapore,2011,40(11):482-487.
[8] 徐偉,王志巖,師佩蘭,等.動力髖螺釘治療老年性股骨粗隆間骨折的療效分析[J].中華全科醫(yī)學(xué),2014,12(7):1044-1046.
[9] ZENG C,WANG YR,WEI J,et al.Treatment of trochanteric fractures with proximal femoral nail antirotation or dynamic hip screw systems:a meta-analysis[J].J Int Med Res,2012,40(3):839-851.
[10] 錢明權(quán),朱國興,陳剛.動力髖螺釘聯(lián)合防旋阻擋釘與股骨近端髓內(nèi)釘治療不穩(wěn)定型股骨粗隆間骨折的對比研究[J].中國矯形外科雜志,2013,21(10):957-962.
[11] 李士紅,劉陽.骨關(guān)節(jié)病變及骨折患者圍術(shù)期骨代謝標(biāo)志物檢測及骨密度變化[J].中國組織工程研究,2016,20(35):5290-5295.
[12] 陳鑫,朱雄白,林文軍,等.仙靈骨葆膠囊治療絕經(jīng)后骨質(zhì)疏松的療效及其機(jī)制研究[J].中國臨床藥理學(xué)雜志,2015,31(10):827-829.
[13] 覃裕,邱冰,朱思剛,等.仙靈骨葆膠囊治療骨質(zhì)疏松癥的療效及其對骨代謝及骨轉(zhuǎn)換指標(biāo)的影響分析[J].中國骨質(zhì)疏松雜志,2015,21(9):1056-1060.
[14] ZHANG G,QIN L,SHI Y.Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women:a 24-month randomized,double-blind and placebo-controlled trial[J].J Bone Miner Res,2007,22(7):1072-1079.
[15] ZHU HM,QIN L,GARNERO P,et al.The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis[J].Osteoporos Int,2012,23(4):1317-1327.
[16] 黃冬,官堂明,馬曉鸝.仙靈骨葆膠囊對骨質(zhì)疏松性骨折預(yù)后的Meta分析[J].今日藥學(xué),2015,25(10):694-696.
相似文獻(xiàn)/References:
[1]鄧紅敏,劉志誠.轉(zhuǎn)子間斜行截骨結(jié)合股骨近端防旋髓內(nèi)釘固定治療
股骨近端骨折術(shù)后髖內(nèi)翻畸形[J].中醫(yī)正骨,2015,27(10):17.
[2]朱云森,江敞,李俊.氨甲環(huán)酸對老年股骨轉(zhuǎn)子間骨折髓內(nèi)固定術(shù)
圍手術(shù)期隱性失血的影響[J].中醫(yī)正骨,2015,27(06):16.
ZHU Yunsen,JIANG Chang,LI Jun.Effect of tranexamic acid on perioperative hidden blood loss in aged patients receiving intramedullary fixation for treatment of intertrochanteric fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):16.
[3]潘雄,劉其順,應(yīng)行,等.中藥聯(lián)合4步康復(fù)鍛煉法對骨質(zhì)疏松性椎體壓縮
骨折患者生存質(zhì)量的影響[J].中醫(yī)正骨,2015,27(04):65.
[4]宋永枝,陳雙玲.唑來膦酸靜脈滴注聯(lián)合鮭降鈣素肌肉注射治療
骨質(zhì)疏松性長骨骨折[J].中醫(yī)正骨,2016,28(01):70.
[5]焦 鋒.益腎活血中藥對股骨轉(zhuǎn)子間骨折患者術(shù)后血清堿性磷酸酶和血清總鈣濃度的影響[J].中醫(yī)正骨,2016,28(04):16.
JIAO Feng.Effect of Yishen Huoxue(益腎活血)traditional Chinese medicine on postoperative serum concentrations of alkaline phosphatase and total calcium in patients with intertrochanteric fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(07):16.
[6]任東坡,倘艷鋒.股骨近端防旋髓內(nèi)釘內(nèi)固定治療不穩(wěn)定型股骨轉(zhuǎn)子間骨折[J].中醫(yī)正骨,2016,28(07):61.
[7]陳建德,樊曉琦,夏炳江,等.球囊擴(kuò)張部位對椎體后凸成形術(shù)治療骨質(zhì)疏松性椎體壓縮骨折療效及安全性的影響[J].中醫(yī)正骨,2017,29(02):11.
CHEN Jiande,FAN Xiaoqi,XIA Bingjiang,et al.Influence of balloon dilation position on curative effect and safety of percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(07):11.
[8]王慶東,徐向峰,金艷南,等.生物型加長柄人工股骨頭置換術(shù)治療高齡不穩(wěn)定性股骨轉(zhuǎn)子間骨折[J].中醫(yī)正骨,2017,29(02):34.
[9]史曉林,王健,王博,等.脆性骨折的防治進(jìn)展[J].中醫(yī)正骨,2017,29(05):20.
[10]曾武,林曙峰,朱俊峰,等.女性骨質(zhì)疏松性橈骨遠(yuǎn)端骨折鎖定鋼板內(nèi)固定術(shù)后腕關(guān)節(jié)功能恢復(fù)的影響因素分析[J].中醫(yī)正骨,2017,29(08):39.
ZENG Wu,LIN Shufeng,ZHU Junfeng,et al.Analysis of factors influencing wrist function recovery after locking plate internal fixation for treatment of osteoporotic distal radius fractures in female[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(07):39.
[11]吳鵬,王博,孔令成,等.強(qiáng)骨飲顆粒聯(lián)合阿侖膦酸鈉維D3片口服在原發(fā)性骨質(zhì)疏松性髖部骨折術(shù)后抗骨質(zhì)疏松治療中的應(yīng)用[J].中醫(yī)正骨,2016,28(05):16.
WU Peng,WANG Bo,KONG Lingcheng,et al.Oral application of Qiangguyin Keli(強(qiáng)骨飲顆粒)and alendronate sodium Vitamin D3 tablets in postoperative anti-osteoporosis treatment in patients with primary osteoporotic hip fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(07):16.